After a chapter defining the concept of treatment resistance and a chapter on its economic impact, five chapters discuss the biological basis for treatment resistance (e.g., neuroendocrine, sleep physiological, immunologic, and brain imaging findings). The next six chapters review the evidence for treatment with serotonin and serotonin-norepinephrine reuptake inhibitors, the monoamine oxidase inhibitors, medication combinations, ECT, thyroid augmentation, and psychotherapeutic and psychosocial treatments.